Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This study investigates the safety and tolerability as well as the efficacy and
pharmacokinetics of caspofungin in four escalating dosages in adult patients with hematologic
malignancies and proven or probable invasive aspergillosis.